Maharashtra FDA Implements Strict Regulations on Infant Foods
New compliance order mandates FSSAI licenses and bans misleading claims in infant food marketing.
Maharashtra FDA enforces regulations on infant food production and marketing.
Prohibits misleading claims and requires clear labeling on products.
Non-compliance can lead to severe penalties, including fines and imprisonment.
In a significant move to enhance food safety for infants, the Maharashtra Food and Drug Administration (FDA) has issued a new compliance order that imposes stringent regulations on the manufacture, distribution, and marketing of infant foods across the state. This order, announced by Commissioner Tukaram Mundhe, takes effect immediately and aims to ensure that products marketed for infant nutrition meet specific safety and quality standards.
The regulations require that all infant food products must be manufactured under a valid FSSAI license, with clear labeling that includes critical health warnings. Notably, the labels must state, "IMPORTANT NOTICE – MOTHER’S MILK IS BEST FOR YOUR BABY," and include guidelines on usage, preparation, and feeding practices. Additionally, any claims regarding the absence of added sugars or other ingredients must be truthful and substantiated.
The order also prohibits the use of promotional images, such as pictures of infants or women, and bans terms like "complete food" or "health food" that could mislead consumers. Furthermore, all forms of advertising, including discounts, free samples, and influencer promotions related to infant foods, are strictly banned across all platforms, including social media and e-commerce sites.
These measures are designed to protect infants from potential health risks associated with misleading marketing and unsafe food products. The FDA has urged hospitals and healthcare professionals to report any adverse events linked to infant foods, including allergic reactions and foodborne illnesses, to facilitate prompt investigations and ensure consumer safety.
Failure to comply with these new regulations could result in severe penalties, including fines up to Rs 10 lakh for misleading advertisements and unlicensed operations, as well as potential imprisonment for serious violations. The FDA's proactive approach aims to safeguard the health of infants in Maharashtra and ensure that parents can trust the products available in the market.
